Market Overview:
The global mycoplasma pneumoniae antibodies market is expected to grow at a CAGR of 6.5% from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of mycoplasma pneumoniae infections, rising demand for monoclonal antibodies, and technological advancements in the field of antibody production. Based on type, the global mycoplasma pneumoniae antibodies market is segmented into monoclonal and polyclonal antibodies. Monoclonal antibodies are expected to account for a larger share of the market than polyclonal antibodies during the forecast period. This can be attributed to their high specificity and affinity for their target antigen, which leads to better performance than polyclonal antibodies. Based on application, hospitals & diagnostic laboratories accounted for the largest share of the global mycoplasma pneumoniae antibody market in 2017.
Product Definition:
Mycoplasma pneumoniae antibodies are produced in response to the presence of Mycoplasma pneumoniae bacteria. These antibodies attach to the bacteria, preventing it from multiplying and causing infection. The importance of mycoplasma pneumoniae antibodies is that they can be used as a diagnostic tool for detecting this particular type of bacterial infection.
Monoclonal:
Monoclonal antibodies are antibody molecules, which are produced by the immune system to fight against bacteria, viruses or other harmful substances. The body's immune system normally creates a set of antibodies to help it identify and attack any foreign objects. However, sometimes the body's immune system produces an antibody that is not useful for identifying or fighting off infections and diseases but instead becomes attached to some harmless proteins in the blood such as those of cardiac muscle cells or endothelial cells.
Polyclonal:
Polyclonal antibodies are made by B cells and are used by the immune system to identify and attack foreign substances. They can recognize a wide range of molecules such as hormones, enzymes, proteins, antigens, tumor-cell antigens etc. Polyclonal antibodies can recognize several epitopes thus making them an important tool in immunology research.
Application Insights:
The global mycoplasma pneumoniae antibodies market is segmented on the basis of application into hospitals & diagnostic laboratories, pharmaceutical & biotechnology, research institutes and others. Hospitals & diagnostic laboratories held the largest share in 2017 owing to increasing prevalence of hospital-acquired infections. This segment is also anticipated to grow at a lucrative rate during the forecast period.
Pharmaceutical and biotechnology companies are engaged in extensive R&D for identification and development of drugs against MPSSI-1 infection which accounts for majority of cases globally due to high product demand from countries such as China, India, Brazil etc., where it is used extensively for diagnosis or treatment purposes against MPSSI-1 infection.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of players, increasing R&D investments by these companies, and favorable reimbursement policies for novel therapies. The region is expected to maintain its dominance throughout the forecast period owing to continuous innovations in diagnostics and therapeutics.
Asia Pacific is anticipated to witness lucrative growth over the forecast period due to factors such as rising healthcare expenditure & awareness about mycoplasma pneumoniae infection among people coupled with government initiatives for improving healthcare infrastructure & availability of effective treatment methods at affordable prices. These factors are likely to contribute toward regional growth during the estimated time span from 2018-2030 (see Figure 1).
Growth Factors:
- Increasing incidence of Mycoplasma pneumoniae infections: The incidence of Mycoplasma pneumoniae infections is increasing globally due to various factors such as changing lifestyle, growing air pollution, and increasing number of immunocompromised patients. This is expected to drive the demand for mycoplasma pneumoniae antibodies over the forecast period.
- Growing awareness about mycoplasma pneumoniae infections: There is a growing awareness among people about mycoplasma pneumoniae infections and its diagnosis and treatment options. This is likely to boost the demand for mycoplasma pneumoniae antibodies in the coming years.
- Technological advancements in antibody-based diagnostics: There has been a significant advancement in antibody-based diagnostics technologies over the past few years, which is aiding in early diagnosis of mycoplasma pneumoniae infections. This is likely to fuel the growth of global mycopalsma pneumonaie antibodies market during the forecast period.
Scope Of The Report
Report Attributes
Report Details
Report Title
Mycoplasma Pneumoniae Antibodies Market Research Report
By Type
Monoclonal, Polyclonal
By Application
Hospitals & Diagnostic Laboratories, Pharmaceutical & Biotechnology, Research Institutes, Others
By Companies
Abbexa Ltd, Abcam, Abnova Corporation, American Research Products Inc., Bio-Rad, Biorbyt, Creative Biolabs, EastCoast Bio, Fitzgerald Industries International, GeneTex, GRP GmbH, LifeSpan BioSciences, MyBioSource.com, Novus Biologicals, OriGene Technologies, ProSci, Inc, Thermo Fisher Scientific, United States Biological
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
206
Number of Tables & Figures
145
Customization Available
Yes, the report can be customized as per your need.
Global Mycoplasma Pneumoniae Antibodies Market Report Segments:
The global Mycoplasma Pneumoniae Antibodies market is segmented on the basis of:
Types
Monoclonal, Polyclonal
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals & Diagnostic Laboratories, Pharmaceutical & Biotechnology, Research Institutes, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbexa Ltd
- Abcam
- Abnova Corporation
- American Research Products Inc.
- Bio-Rad
- Biorbyt
- Creative Biolabs
- EastCoast Bio
- Fitzgerald Industries International
- GeneTex
- GRP GmbH
- LifeSpan BioSciences
- MyBioSource.com
- Novus Biologicals
- OriGene Technologies
- ProSci, Inc
- Thermo Fisher Scientific
- United States Biological
Highlights of The Mycoplasma Pneumoniae Antibodies Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Monoclonal
- Polyclonal
- By Application:
- Hospitals & Diagnostic Laboratories
- Pharmaceutical & Biotechnology
- Research Institutes
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Mycoplasma Pneumoniae Antibodies Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Mycoplasma pneumoniae antibodies are a type of antibody that is produced in response to the presence of Mycoplasma pneumoniae. These antibodies can help protect against infection with Mycoplasma pneumoniae and may provide some relief from symptoms.
Some of the major players in the mycoplasma pneumoniae antibodies market are Abbexa Ltd, Abcam, Abnova Corporation, American Research Products Inc., Bio-Rad, Biorbyt, Creative Biolabs, EastCoast Bio, Fitzgerald Industries International, GeneTex, GRP GmbH, LifeSpan BioSciences, MyBioSource.com, Novus Biologicals, OriGene Technologies, ProSci, Inc, Thermo Fisher Scientific, United States Biological.
The mycoplasma pneumoniae antibodies market is expected to grow at a compound annual growth rate of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Mycoplasma Pneumoniae Antibodies Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Mycoplasma Pneumoniae Antibodies Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Mycoplasma Pneumoniae Antibodies Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Mycoplasma Pneumoniae Antibodies Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Mycoplasma Pneumoniae Antibodies Market Size & Forecast, 2018-2028
4.5.1 Mycoplasma Pneumoniae Antibodies Market Size and Y-o-Y Growth
4.5.2 Mycoplasma Pneumoniae Antibodies Market Absolute $ Opportunity
Chapter 5 Global Mycoplasma Pneumoniae Antibodies Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Mycoplasma Pneumoniae Antibodies Market Size Forecast by Type
5.2.1 Monoclonal
5.2.2 Polyclonal
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Mycoplasma Pneumoniae Antibodies Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Mycoplasma Pneumoniae Antibodies Market Size Forecast by Applications
6.2.1 Hospitals & Diagnostic Laboratories
6.2.2 Pharmaceutical & Biotechnology
6.2.3 Research Institutes
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Mycoplasma Pneumoniae Antibodies Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Mycoplasma Pneumoniae Antibodies Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Mycoplasma Pneumoniae Antibodies Analysis and Forecast
9.1 Introduction
9.2 North America Mycoplasma Pneumoniae Antibodies Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Mycoplasma Pneumoniae Antibodies Market Size Forecast by Type
9.6.1 Monoclonal
9.6.2 Polyclonal
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Mycoplasma Pneumoniae Antibodies Market Size Forecast by Applications
9.10.1 Hospitals & Diagnostic Laboratories
9.10.2 Pharmaceutical & Biotechnology
9.10.3 Research Institutes
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Mycoplasma Pneumoniae Antibodies Analysis and Forecast
10.1 Introduction
10.2 Europe Mycoplasma Pneumoniae Antibodies Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Mycoplasma Pneumoniae Antibodies Market Size Forecast by Type
10.6.1 Monoclonal
10.6.2 Polyclonal
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Mycoplasma Pneumoniae Antibodies Market Size Forecast by Applications
10.10.1 Hospitals & Diagnostic Laboratories
10.10.2 Pharmaceutical & Biotechnology
10.10.3 Research Institutes
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Mycoplasma Pneumoniae Antibodies Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Mycoplasma Pneumoniae Antibodies Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Mycoplasma Pneumoniae Antibodies Market Size Forecast by Type
11.6.1 Monoclonal
11.6.2 Polyclonal
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Mycoplasma Pneumoniae Antibodies Market Size Forecast by Applications
11.10.1 Hospitals & Diagnostic Laboratories
11.10.2 Pharmaceutical & Biotechnology
11.10.3 Research Institutes
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Mycoplasma Pneumoniae Antibodies Analysis and Forecast
12.1 Introduction
12.2 Latin America Mycoplasma Pneumoniae Antibodies Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Mycoplasma Pneumoniae Antibodies Market Size Forecast by Type
12.6.1 Monoclonal
12.6.2 Polyclonal
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Mycoplasma Pneumoniae Antibodies Market Size Forecast by Applications
12.10.1 Hospitals & Diagnostic Laboratories
12.10.2 Pharmaceutical & Biotechnology
12.10.3 Research Institutes
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Mycoplasma Pneumoniae Antibodies Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Mycoplasma Pneumoniae Antibodies Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Mycoplasma Pneumoniae Antibodies Market Size Forecast by Type
13.6.1 Monoclonal
13.6.2 Polyclonal
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Mycoplasma Pneumoniae Antibodies Market Size Forecast by Applications
13.10.1 Hospitals & Diagnostic Laboratories
13.10.2 Pharmaceutical & Biotechnology
13.10.3 Research Institutes
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Mycoplasma Pneumoniae Antibodies Market: Competitive Dashboard
14.2 Global Mycoplasma Pneumoniae Antibodies Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbexa Ltd
14.3.2 Abcam
14.3.3 Abnova Corporation
14.3.4 American Research Products Inc.
14.3.5 Bio-Rad
14.3.6 Biorbyt
14.3.7 Creative Biolabs
14.3.8 EastCoast Bio
14.3.9 Fitzgerald Industries International
14.3.10 GeneTex
14.3.11 GRP GmbH
14.3.12 LifeSpan BioSciences
14.3.13 MyBioSource.com
14.3.14 Novus Biologicals
14.3.15 OriGene Technologies
14.3.16 ProSci, Inc
14.3.17 Thermo Fisher Scientific
14.3.18 United States Biological
